Regeneron Pharma (REGN) PT Lowered at Bernstein Following a 'Disappointing Result'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $750.00 (from $896.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
